WCM Investment Management LLC Sells 59,263 Shares of Addus HomeCare Corporation $ADUS

WCM Investment Management LLC lessened its position in Addus HomeCare Corporation (NASDAQ:ADUS) by 12.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 429,797 shares of the company’s stock after selling 59,263 shares during the period. WCM Investment Management LLC’s holdings in Addus HomeCare were worth $50,626,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in ADUS. AlphaQuest LLC bought a new position in Addus HomeCare during the 3rd quarter valued at about $37,000. Arizona State Retirement System increased its holdings in shares of Addus HomeCare by 2.6% during the third quarter. Arizona State Retirement System now owns 5,436 shares of the company’s stock worth $641,000 after buying an additional 136 shares in the last quarter. Cambiar Investors LLC raised its stake in shares of Addus HomeCare by 10.1% in the third quarter. Cambiar Investors LLC now owns 14,179 shares of the company’s stock valued at $1,673,000 after acquiring an additional 1,299 shares during the last quarter. Huntleigh Advisors Inc. raised its stake in shares of Addus HomeCare by 6.3% in the third quarter. Huntleigh Advisors Inc. now owns 4,222 shares of the company’s stock valued at $498,000 after acquiring an additional 251 shares during the last quarter. Finally, Amalgamated Bank boosted its holdings in shares of Addus HomeCare by 1.8% in the 3rd quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock worth $618,000 after acquiring an additional 93 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Price Performance

Shares of ADUS stock opened at $105.32 on Tuesday. The firm has a market cap of $1.95 billion, a price-to-earnings ratio of 22.55, a PEG ratio of 1.24 and a beta of 0.91. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $126.13. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.14. The stock has a 50-day moving average price of $111.58 and a 200 day moving average price of $112.95.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 3rd. The company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.03. The company had revenue of $362.30 million for the quarter, compared to analyst estimates of $354.48 million. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. The company’s revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.30 EPS. Research analysts expect that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, EVP Darby Anderson sold 20,000 shares of Addus HomeCare stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the completion of the sale, the executive vice president owned 44,144 shares of the company’s stock, valued at approximately $4,811,696. The trade was a 31.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold 20,316 shares of company stock valued at $2,215,998 over the last quarter. 4.50% of the stock is currently owned by company insiders.

Analyst Ratings Changes

ADUS has been the subject of a number of recent analyst reports. BMO Capital Markets assumed coverage on Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target for the company. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Barclays upped their price target on shares of Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 4th. TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Finally, Wall Street Zen downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, January 25th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $135.44.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.